Multivariate indicators of disease severity in COVID-19

Abstract

The novel coronavirus pandemic continues to cause significant morbidity and mortality around the world. Diverse clinical presentations prompted numerous attempts to predict disease severity to improve care and patient outcomes. Equally important is understanding the mechanisms underlying such divergent disease outcomes. Multivariate modeling was used here to define the most distinctive features that separate COVID-19 from healthy controls and severe from moderate disease. Using discriminant analysis and binary logistic regression models we could distinguish between severe disease, moderate disease, and control with rates of correct classifications ranging from 71 to 100%. The distinction of severe and moderate disease was most reliant on the depletion of natural killer cells and activated class-switched memory B cells, increased frequency of neutrophils, and decreased expression of the activation marker HLA-DR on monocytes in patients with severe disease. An increased frequency of activated class-switched memory B cells and activated neutrophils was seen in moderate compared to severe disease and control. Our results suggest that natural killer cells, activated class-switched memory B cells, and activated neutrophils are important for protection against severe disease. We show that binary logistic regression was superior to discriminant analysis by attaining higher rates of correct classification based on immune profiles. We discuss the utility of these multivariate techniques in biomedical sciences, contrast their mathematical basis and limitations, and propose strategies to overcome such limitations.

Influence of simultaneous comorbidities on COVID-associated acute respiratory distress syndrome mortality in people with diabetes

“…The adjustments for demographic factors in our regression models were carefully chosen based on existing literature indicating their potential confounding effects on the relationship between comorbidities and mortality outcomes. 19 , 20 By adjusting for these factors, we presented a more accurate and nuanced analysis that reflects the real-world complexity of CARDS mortality risk in individuals with diabetes. We analyzed the odds ratio in a 95% confidence interval (95% CI) to determine the degree of risk.…”

SARS-CoV-2 Infections, Vaccination, and Vaccine Effectiveness in Thailand, January 2021–January 2022: Results of a Cohort Study in Four Provinces

“…We randomly selected 5 (of 50) districts with probability proportional to size of the population. Stratifying the official list of Thai registered citizens into three age groups (5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18), and >60 years), we then conducted simple random sampling within each age group. We recruited 75 persons aged 5-18, 150 persons aged 19-59, and 75 persons aged 60 years and older in each province.…”

Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry

“…COVID-19 caused by infections with SARS-CoV-2 are accompanied by heterogeneous indications ranging from asymptomatic infections to serious and life-threatening manifestations, representing a major challenge to foretell COVID-19 disease outcome ( Bean et al, 2023 ). Besides advanced age and male sex ( Booth et al, 2021 ; Sieurin et al, 2022 ), other predictors for adverse outcomes in SARS-CoV-2–infected patients include obesity, cardiovascular disease, hypertension, type 2 diabetes, and other diseases such as cancer, kidney diseases, obstructive pulmonary disease, or pre-existing cerebrovascular and respiratory diseases ( Booth et al, 2021 ; Cheng et al, 2021 ; Ng et al, 2021 ; Westheim et al, 2021 ).…”